首页> 外文期刊>Environmental Pollution >Mineralization, metabolism and formation of non-extractable residues of ~(14)C-labelled organic contaminants during pilot-scale composting of municipal biowaste
【24h】

Mineralization, metabolism and formation of non-extractable residues of ~(14)C-labelled organic contaminants during pilot-scale composting of municipal biowaste

机译:〜(14)C标记的有机污染物在城市生物垃圾中试堆肥过程中的矿化,代谢和不可提取的残留物的形成

获取原文
获取原文并翻译 | 示例
       

摘要

Use of municipal biowaste for composting instead of its disposal has become a major source of concern as regards contamination by hazardous substances. To elucidate the hazard potential of compost application, municipal biowaste was amended with ~(14)C-labelled model substances (pyrene, simazine) and incubated in a pilot-scale composting simulation system. A mass balance incorporating the mineralization, metabolism and sorption of the two model substances was established over a period of 370 days. The results are quite different for the two chemicals, reflecting their intrinsic properties: more than 60% of the applied ~(14)C-simazine resulted in non-extractable residues (NER). Silylation experiments indicated that the formation of NER from simazine and its metabolites was due to both physical entrapment in the matrix and chemical binding. The mineralization and formation of NER represented the major pathways of disappearance for pyrene during one year of composting, accounting for 60 and 26% of initially applied ~(14)C-activity, respectively. Mineralization occurred delayed after the thermophilic phase. As regards remobilization, release of pyrene from NER during composting could be excluded, whereas simazine, data were inconclusive in this respect.
机译:对于有害物质的污染,使用市政生物废料代替堆肥已成为人们关注的主要问题。为了阐明堆肥的潜在危害,市政生物废料用〜(14)C标记的模型物质(p​​y,西马津)进行了修正,并在中试堆肥模拟系统中进行了培养。在370天的时间内建立了包括两种矿物质的矿化,代谢和吸附在内的质量平衡。两种化学药品的结果差异很大,反映出它们的内在特性:施加的〜(14)C-辛嗪中超过60%的化合物产生不可提取的残留物(NER)。硅烷化实验表明,辛嗪及其代谢产物形成NER的原因是基质中的物理截留和化学结合。 NER的矿化和形成代表pyr堆肥过程中pyr消失的主要途径,分别占最初应用的〜(14)C活性的60%和26%。嗜热阶段后矿化发生延迟。关于迁移,可以排除堆肥过程中从NER释放release,而对于simazine,在这方面数据尚无定论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号